Stereotaxis reports Q3 EPS (7c), consensus (6c) STXS

2023-11-09 09:05:36 STXS Stereotaxis $1.67 / -0.085 (-4.84%) 09:05 11/09/23 11/09 09:05 11/09/23 09:05	Stereotaxis reports Q3 EPS (7c), consensus (6c)	09 Nov
Available to The Fly Members Only Breaking content available to members only. Sign up or login for access. Create FREE Account

OTHER BREAKING NEWS FROM THE FLY

Hot Stocks	Replimune presents primary analysis data from IGNYTE clinical trial » 10:02 09/15/24 09/15 10:02 09/15/24 10:02 REPL Replimune $11.12 / +0.74 (+7.13%) Replimune Group announced… Available to The Fly Members Only Breaking content available to members only. Sign up or login for access. Create FREE Account
Hot Stocks	Alcoa announces agreement to sell 25.1% stake in Ma'aden JV to Ma'aden » 09:58 09/15/24 09/15 09:58 09/15/24 09:58 AA Alcoa $32.50 / +1.14 (+3.64%) Alcoa announced that it… Available to The Fly Members Only Breaking content available to members only. Sign up or login for access. Create FREE Account
Hot Stocks	Bristol Myers presents landmark 10-year follow-up data from CheckMate -067 » 09:55 09/15/24 09/15 09:55 09/15/24 09:55 BMY Bristol Myers $49.17 / +0.95 (+1.97%) Bristol Myers announced… Available to The Fly Members Only Breaking content available to members only. Sign up or login for access. Create FREE Account
Hot Stocks	Merck announces long-term OS data from pivotal Phase 3 KEYNOTE-006 trial » 09:51 09/15/24 09/15 09:51 09/15/24 09:51 MRK Merck $116.14 / +0.83 (+0.72%) Merck announced long-term… Available to The Fly Members Only Breaking content available to members only. Sign up or login for access. Create FREE Account
Hot Stocks	Exelixis presents final overall survival results from Phase 3 CONTACT-02 study » 09:38 09/15/24 09/15 09:38 09/15/24 09:38 EXEL Exelixis $26.44 / +0.13 (+0.49%) Exelixis announced… Available to The Fly Members Only Breaking content available to members only. Sign up or login for access. Create FREE Account
Hot Stocks	Genmab announces new data from Phase 1/2 study of Rina-S » 09:32 09/15/24 09/15 09:32 09/15/24 09:32 GMAB Genmab $26.90 / +0.41 (+1.55%) Genmab announced new data… Available to The Fly Members Only Breaking content available to members only. Sign up or login for access. Create FREE Account
Hot Stocks	Veracyte announces new data from Phase 3 STAMPEDE clinical trial » 09:29 09/15/24 09/15 09:29 09/15/24 09:29 VCYT Veracyte $32.93 / +2.5 (+8.22%) Veracyte announced that… Available to The Fly Members Only Breaking content available to members only. Sign up or login for access. Create FREE Account
Hot Stocks	Lantheus presents results from primary analysis of Phase 3 pivotal SPLASH trial » 09:17 09/15/24 09/15 09:17 09/15/24 09:17 LNTH Lantheus $105.51 / +1.49 (+1.43%) Lantheus presented… Available to The Fly Members Only Breaking content available to members only. Sign up or login for access. Create FREE Account
Hot Stocks	MacroGenics announces updated efficacy, safety data from TAMARACK Phase 2 study » 09:15 09/15/24 09/15 09:15 09/15/24 09:15 MGNX MacroGenics $3.71 / +0.09 (+2.49%) MacroGenics presented… Available to The Fly Members Only Breaking content available to members only. Sign up or login for access. Create FREE Account
Hot Stocks	23andMe presents preliminary Phase 2 safety, efficacy data from Phase 1/2a trial » 09:09 09/15/24 09/15 09:09 09/15/24 09:09 ME 23andMe / + 23andMe announced… Available to The Fly Members Only Breaking content available to members only. Sign up or login for access. Create FREE Account

Hot Stocks	23andMe announces in vivo results for 23ME-01473 in Phase 1 trial » 09:06 09/15/24 09/15 09:06 09/15/24 09:06 ME 23andMe / + 23andMe announced… Available to The Fly Members Only Breaking content available to members only. Sign up or login for access. Create FREE Account
Hot Stocks	J&J announces additional results from pivotal Phase 2b SunRISe-1 study » 09:04 09/15/24 09/15 09:04 09/15/24 09:04 JNJ Johnson & Johnson $165.52 / +0.85 (+0.52%) Johnson & Johnson… Available to The Fly Members Only Breaking content available to members only. Sign up or login for access. Create FREE Account
Hot Stocks	Natera announces new data from GALAXY arm of ongoing CIRCULATE-Japan trial » 09:01 09/15/24 09/15 09:01 09/15/24 09:01 NTRA Natera $127.17 / +2.06 (+1.65%) Natera announced that new… Available to The Fly Members Only Breaking content available to members only. Sign up or login for access. Create FREE Account
Hot Stocks	Masimo, Qualcomm to develop next-gen smartwatch reference platform for OEMs » 08:58 09/15/24 09/15 08:58 09/15/24 08:58 MASI Masimo $114.50 / +1.48 (+1.31%) , QCOM Qualcomm $167.35 / +2.37 (+1.44%) , GOOG Alphabet $158.00 / +2.08 (+1.33%) , GOOGL Alphabet $157.20 / +2.44 (+1.58%) Masimo (MASI) and… Available to The Fly Members Only Breaking content available to members only. Sign up or login for access. Create FREE Account
Hot Stocks	Incyte announces new early clinical data for INCB123667 » 08:55 09/15/24 09/15 08:55 09/15/24 08:55 INCY Incyte $63.56 / +0.205 (+0.32%) Incyte announced new… Available to The Fly Members Only Breaking content available to members only. Sign up or login for access. Create FREE Account
Hot Stocks	Merck, Eisai announce results from interim analysis of Phase 3 LEAP-012 trial » 08:50 09/15/24 09/15 08:50 09/15/24 08:50 MRK Merck $116.14 / +0.83 (+0.72%) , ESAIY Eisai $10.26 / -0.05 (-0.48%) Merck (MRK) and Eisai… Available to The Fly Members Only Breaking content available to members only. Sign up or login for access. Create FREE Account
Hot Stocks	Merck announces OS results from pivotal Phase 3 KEYNOTE-A18 trial » 08:41 09/15/24 09/15 08:41 09/15/24 08:41 MRK Merck $116.14 / +0.83 (+0.72%) Merck announced the first… Available to The Fly Members Only Breaking content available to members only. Sign up or login for access. Create FREE Account
Hot Stocks	Incyte announced results from Phase 3 POD1UM-303/InterAACT2 trial » 08:12 09/15/24 09/15 08:12 09/15/24 08:12 INCY Incyte $63.56 / +0.205 (+0.32%) Incyte announced results… Available to The Fly Members Only Breaking content available to members only. Sign up or login for access. Create FREE Account
Hot Stocks	Johnson & Johnson announces new data from Phase 1b/2 OrigAMI-1 study » 08:07 09/15/24 09/15 08:07 09/15/24 08:07 JNJ Johnson & Johnson $165.52 / +0.85 (+0.52%) Johnson & Johnson… Available to The Fly Members Only Breaking content available to members only. Sign up or login for access. Create FREE Account
Hot Stocks	Pfizer presents data from Phase 2 study of ponsegromab in with cancer cachexia » 08:04 09/15/24 09/15 08:04 09/15/24 08:04 PFE Pfizer $29.20 / +0.03 (+0.10%) Pfizer announced its… Available to The Fly Members Only Breaking content available to members only. Sign up or login for access. Create FREE Account

Hot Stocks	Nuvalent highlights presentation of data from parallel lead programs » 08:00 09/15/24 09/15 08:00 09/15/24 08:00 NUVL Nuvalent $87.45 / +5.78 (+7.08%) Nuvalent highlighted the… Available to The Fly Members Only Breaking content available to members only. Sign up or login for access. Create FREE Account
Hot Stocks	Cullinan presents data from Module C of Zipalertinib pivotal Phase 2b study » 07:53 09/15/24 09/15 07:53 09/15/24 07:53 CGEM Cullinan Therapeutics $17.96 / +0.37 (+2.10%) Cullinan Therapeutics… Available to The Fly Members Only Breaking content available to members only. Sign up or login for access. Create FREE Account
Hot Stocks	Pfizer announces follow-up results from Phase 2 single-arm PHAROS trial » 07:50 09/15/24 09/15 07:50 09/15/24 07:50 PFE Pfizer $29.20 / +0.03 (+0.10%) Pfizer announced… Available to The Fly Members Only Breaking content available to members only. Sign up or login for access. Create FREE Account
Hot Stocks	Merck announces OS results from final analysis of Phase 3 KEYNOTE-811 trial » 07:42 09/15/24 09/15 07:42 09/15/24 07:42 MRK Merck $116.14 / +0.83 (+0.72%) Merck announced overall… Available to The Fly Members Only Breaking content available to members only. Sign up or login for access. Create FREE Account
Hot Stocks	J&J announces updated results from Phase 3 MARIPOSA-2 study » 07:37 09/15/24 09/15 07:37 09/15/24 07:37 JNJ Johnson & Johnson $165.52 / +0.85 (+0.52%) Johnson & Johnson… Available to The Fly Members Only Breaking content available to members only. Sign up or login for access. Create FREE Account

Events

Earnings calls, analyst events, roadshows and more

BSX
Tomorrow at 00:00

Boston Scientific - BSX Conference Calls
Tomorrow at 00:00

Financial Investors Tour of Puerto Rico Conferences

San Juan
Tomorrow at 00:00

ESMO Congress 2024 Conferences

Barcelona
Tomorrow at 00:00

Futures Industry Association Forum: Commodities 2024 Conferences

Houston, TX
VOYA
Tomorrow at 00:00

Voya Financial Firm Sponsored Meetings

London
ENVX
Tomorrow at 00:00

Enovix Firm Sponsored Meetings

London
REAX
Tomorrow at 00:00

Real Brokerage Firm Sponsored Meetings

Boston, MA
AIN
Tomorrow at 00:00

Albany International Firm Sponsored Meetings

Midwest
NRIX
Tomorrow at 00:00

Nurix Therapeutics Firm Sponsored Meetings
FOXF
Tomorrow at 00:00

Fox Factory Firm Sponsored Meetings

Denver, CO

View All Events »

1 of

Syndicate

This week’s upcoming IPOs and secondary offerings

Priced
Not Priced

Mon	No deals
Tues	No deals
Wed	No deals
Thurs	No deals
Fri	No deals

Mon	No deals
Tues	No deals
Wed	No deals
Thurs	No deals
Fri	No deals

View All Syndicate Announcements »

Stereotaxis reports Q3 EPS (7c), consensus (6c)

OTHER BREAKING NEWS FROM THE FLY

Get Full Fly Access